Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipid Metabolism Modulation during SARS-CoV-2 Infection: A Spotlight on Extracellular Vesicles and Therapeutic Prospects. | Int J Mol Sci | 2024 | 38203811 | PubTator, text mining | PubMed |
| Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma. | J Virol | 2024 | 38197630 | PubTator, text mining | PubMed |
First-in-human single-dose study of nizubaglustat, a dual inhibitor of ceramide glucosyltransferase and non-lysosomal glucosylceramidase: Safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending and multiple doses in healthy adults. | Mol Genet Metab | 2024 | 38113551 | PubTator, text mining | PubMed |
| Blocking glycosphingolipid production alters autophagy in osteoclasts and improves myeloma bone disease. | Autophagy | 2024 | 37771244 | PubTator, text mining | PubMed |
| Role of lipid metabolism gene KLF4 in osteoarthritis. | Clin Rheumatol | 2024 | 37608136 | PubTator, text mining | PubMed |
| High-Throughput SARS-CoV-2 Antiviral Testing Method Using the Celigo Image Cytometer. | J Fluoresc | 2024 | 37310590 | PubTator, text mining | PubMed |
| Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology. | Front Physiol | 2023 | 38235387 | PubTator, text mining | PubMed |
| Lipids as Emerging Biomarkers in Neurodegenerative Diseases. | Int J Mol Sci | 2023 | 38203300 | PubTator, text mining | PubMed |
| A rare disease in adult women: Gaucher disease. | J Int Med Res | 2023 | 38150565 | PubTator, text mining | PubMed |
| The Implication of Sphingolipids in Viral Infections. | Int J Mol Sci | 2023 | 38139132 | PubTator, text mining | PubMed |
| Novel Fused Pyrazole Amide Analogs as Glucosylceramide Synthase Inhibitors for Treating Lysosomal Storage Diseases, Neurodegenerative Diseases, Cystic Diseases, and Cancer. | ACS Med Chem Lett | 2023 | 38116443 | PubTator, text mining | PubMed |
| Lipid compartments and lipid metabolism as therapeutic targets against coronavirus. | Front Immunol | 2023 | 38106410 | PubTator, text mining | PubMed |
| Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project. | Orphanet J Rare Dis | 2023 | 38102667 | PubTator, text mining | PubMed |
| Multi-dimensional role of gangliosides in modulating cancer hallmarks and their prospects in targeted cancer therapy. | Front Pharmacol | 2023 | 38089042 | PubTator, text mining | PubMed |
| Sphingolipids in mitochondria-from function to disease. | Front Cell Dev Biol | 2023 | 38078003 | PubTator, text mining | PubMed |
| Opaganib (ABC294640) Induces Immunogenic Tumor Cell Death and Enhances Checkpoint Antibody Therapy. | Int J Mol Sci | 2023 | 38069222 | PubTator, text mining | PubMed |
| In vitro substrate reduction, chaperone and immunomodulation treatments reduce heparan sulfate in mucolipidosis III human fibroblasts. | Genet Mol Biol | 2023 | 38047750 | PubTator, text mining | PubMed |
| Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival. | Clin Transl Med | 2023 | 38037464 | PubTator, text mining | PubMed |
| Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease. | J Neuroinflammation | 2023 | 38037070 | PubTator, text mining | PubMed |
| Crosstalk between septic shock and venous thromboembolism: a bioinformatics and immunoassay analysis. | Front Cell Infect Microbiol | 2023 | 38029239 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=6